Literature DB >> 872269

Photodynamic action of chlorpromazine on adenovirus 5:repairable damage and single strand breaks.

R S Day, M Dimattina.   

Abstract

Chlorpromazine, a substituted phenothiazine, commonly used as a sedative, has been found to photosensitize the inactivation of human adenovirus 5 to wavelengths of light between 330 and 390 nm. The slope of the inactivation curve is three fold greater when fibroblasts from people having xeroderma pigmentosum (XP) were used as viral hosts than when normal fibroblasts were used, showing that at least two-thirds of the damage produced in the virions is repairable by normal human fibroblasts. The phototreatment of chlorpromazine sensitized virions also results in the production of DNA strand breaks, which correlate fairly well with the production of lethal viral damage as measured in XP fibroblasts. These findings suggest that the photosensitization of the skin observed in patients treated with chlorpromazine might be due to DNA damage.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 872269     DOI: 10.1016/0009-2797(77)90074-6

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  4 in total

1.  Photodynamic potentialities of some phenothiazine derivatives.

Authors:  M Saucin; A Van de Vorst
Journal:  Radiat Environ Biophys       Date:  1980-02       Impact factor: 1.925

2.  Photomutagenesis by chlorinated phenothiazine tranquilizers.

Authors:  J G Jose
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

3.  Photochemical inactivation of deoxyribonucleic and ribonucleic acid viruses by chlorpromazine.

Authors:  C V Hanson
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

4.  Photoinduced free radicals from chlorpromazine and related phenothiazines: relationship to phenothiazine-induced photosensitization.

Authors:  C F Chignell; A G Motten; G R Buettner
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.